Intellectual Property Strategy * IPR Attorneys & Patent Research Lawyers

Home » health patents » Genentech & Novartis are the Top Patent filers & Patent recipients Classified under #IPCC12

Genentech & Novartis are the Top Patent filers & Patent recipients Classified under #IPCC12

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,791 other followers

Patent Filing in India

Blog Stats

  • 45,841 hits

Top Patent filers & Patent recipients classified under IPC C12: Genentech, Novartis, Monsanto, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA,  PIONEER HI-BRED INTERNATIONAL, INC., NOVARTIS AG, Monsanto Technology LLC,  ROCHE DIAGNOSTICS GMBH


If you need business advisory services, you can refer to our Business Accelerator (TechCorpCapital), our law firm (TechCorpLegal) and our tech business consultancy (Tech Corp International Consultants, Singapore).

For technology specific advisory, you can refer to our premium service offerings for Mobile Applications, Social Media & Cyber Laws (CyberCorpLegal) and Pharmaceuticals, Biotechnology, Food & Healthcare (BioCorpLegal).

To know more about us, get connected with us on LinkedIn or mail us at info [at] techcorplegal [dot] com

Join the discussion now:

Google Group Discussion Forum

LinkedIn Group: Dev Academy | LinkedIn

Facebook Group: Dev Academy | Facebook

Google Plus: Dev Academy – Google+

Follow us on Twitter: Dev Academy (TheDevAcademy) on Twitter

Follow Dev Academy on Facebook: Dev Academy | Facebook Page

Disclaimer: It is strongly advisable to take professional legal advice and the information presented herein and on this website is personal opinion of the author. Readers are free to share, distribute or disseminate the content of this website by including the text “Copyright 2010-2013, Tech Corp Legal LLP” along with a URL for this web site in each article posted or published elsewhere. The sale or any other commercial exploitation of the content of this website, in whole or in part, is strictly prohibited. More details: Disclaimer, Non-Solicitation & Liability.

%d bloggers like this: